tert-Butyl (5-(benzyloxy)-2-bromophenyl)carbamate

Catalog No. :
ACSHNP115
CAS No. :
119879-92-4
Molecular Formula :
C18H20BrNO3
Molecular Weight :
378.27

IUPAC Name:tert-butyl (5-(benzyloxy)-2-bromophenyl)carbamate

tert-Butyl (5-(benzyloxy)-2-bromophenyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$338.00Login to see priceInquiryInquiry
1g95%$857.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (5-(benzyloxy)-2-bromophenyl)carbamate
IUPAC Nametert-butyl (5-(benzyloxy)-2-bromophenyl)carbamate
MDL No.MFCD16658925
Molecular FormulaC18H20BrNO3
Molecular Weight378.27
SMILESO=C(OC(C)(C)C)NC1=CC(OCC2=CC=CC=C2)=CC=C1Br
InChI KeyBZSHFDPWXSSQFF-UHFFFAOYSA-N
SynonymN-Boc-2-bromo-5-benzyloxyaniline;N-Boc-2-Bromo-5-Benzyloxyanilinen;tert-Butyl (5-(benzyloxy)-2-broMophenyl)carbaMate;N-(tert-butyloxycarbonyl)-2-bromo-5-benzyloxyaniline;N-[2-Bromo-5-(phenylmethoxy)phenyl]carbamic acid tert-butyl ester;Carbamic acid, N-[2-bromo-5-(phenylmethoxy)phenyl]-, 1,1-dimethylethyl ester
CAS No.119879-92-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACSHNP115 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSHNP115 route product structure diagram
    ACSHNP115119879-92-4
Inquiry

2. ACSHNP115 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSHNP115 route product structure diagram
    ACSHNP115119879-92-4
Inquiry

Comments (0)